Histamine-2 Receptor Antagonist [EPC]

304206 reported adverse events

Drugs of this class: FAMOTIDINE CIMETIDINE FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE IBUPROFEN AND FAMOTIDINE FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE NIZATIDINE RANITIDINE FAMOTIDINE 10 MG FAMOTIDINE TABLET, FILM-COATED FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE TABLET, CHEWABLE

These side effects are most commonly reported by patients taking drugs of the Histamine-2 Receptor Antagonist [EPC] class:

#	Side effect	Count
0	BREAST CANCER	24998
1	PROSTATE CANCER	22241
2	COLORECTAL CANCER	17616
3	RENAL CANCER	16270
4	BLADDER CANCER	13570
5	NAUSEA	11099
6	INCORRECT DOSE ADMINISTERED	10639
7	DRUG INEFFECTIVE	10588
8	CHRONIC KIDNEY DISEASE	10554
9	FATIGUE	10364

See all common reactions for Histamine-2 Receptor Antagonist [EPC]

Drugs of the Histamine-2 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER	368	0.3778
1	COLORECTAL CANCER	17616	0.3740
2	RENAL CANCER	16270	0.3524
3	SMALL INTESTINE CARCINOMA	720	0.3478
4	NEPHROGENIC ANAEMIA	1370	0.3166
5	HEPATIC CANCER	6606	0.3072
6	OESOPHAGEAL CARCINOMA	8337	0.3024
7	HYPERPARATHYROIDISM SECONDARY	692	0.3014
8	PROSTATE CANCER	22241	0.2943
9	BREAST CANCER	24998	0.2904

See all enriched reactions for Histamine-2 Receptor Antagonist [EPC]